Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Eradivir Logo
Eradivir Growth Score
77
CB Rank
26540
Heat Score
60
Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.
Founded
obfuscation
PrivateFunding Round West Lafayette, Indiana, United States11-50 www.eradivir.com
Biotechnology
Health Care
Therapeutics
Overview

Eradivir
Total Funding
obfuscation
Growth Score
77
Heat Score
60

Total Funding
obfuscation
obfuscation
Funding Round raised
obfuscation
Growth Score77
-11 pts
in past quarter
Heat Score 60
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Eradivir

CB Rank
26540
Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.
Founded
obfuscation
PrivateFunding Round West Lafayette, Indiana, United States11-50 www.eradivir.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Funding Round
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Philip Low
    Philip Low: Co-Founder, Director & CSO
    Past Role: Endocyte, Co-Founder, Chief Science Officer & Board Member
  • Photo of Martin Low
    Martin Low: Co-Founder & CEO

Details

Legal Name Eradivir, Inc.
Operating Status Active
Company Type For Profit
Founders  Isaac Barchas, Martin Low, Philip Low
About the Company
Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19. The company was founded in 2020 and is headquartered in West Lafayette, Indiana.
Contact Email info@eradivir.com
Predictions & Insights

Growth Insight

See this Growth Insight
Eradivir is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Awards

Products & Services

EV25
A small molecule immunotherapy designed to treat influenza by linking infected cells to anti-hapten antibodies, recruiting the innate immune system to clear the virus.
Bispecific Antigenic immuno-Therapy (BAiT) Platform
A platform technology that creates small molecule immunotherapies which tether immune cells to diseased cells for targeted destruction.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round
obfuscation
Funding Round - Eradivir Logo
Funding Round - Eradivir
—
obfuscation
— Funding Round

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 1 Contacts 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

10
-97.63%
 in past month

IT Spend

$462.9KThis year, Eradivir is projected to spend $462.9K on IT, according to Aberdeen.

Active Website Tech Count

2Eradivir is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 5m.
Sub-Organizations
Frequently Asked Questions

Where is Eradivir's headquarters? Eradivir is located in West Lafayette, Indiana, United States.Who invested in Eradivir? Eradivir has 3 investors including Biomedical Advanced Research and Development Authority (BARDA) and  National Science Foundation.When was the last funding round for Eradivir? Eradivir closed its last funding round on
obfuscation
from a Undisclosed round.Who are Eradivir's competitors? Alternatives and possible competitors to Eradivir may include XtalPi, BioAffinity Technologies, and  Orna Therapeutics.How much funding has Eradivir raised to date? Eradivir has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|